Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dimethylamine | HCID 674 | — |
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | 6-(2-Chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-amine | HCID 12562515 | — |
| Reactant | HCID 20508545 | HCID 20508545 | — |
| Reactant | HCID 20508562 | HCID 20508562 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 20508546 | HCID 20508546 | — |
Reaction Steps
A solution of [6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepin-8-yl]isocyanate, prepared as described in paragraph (a) of Example 1 from 7.0 g (21.6 mmol) of 8-amino-6-(2-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine, but using methylene chloride in place of 1,2-dichloroethane, is treated while stirring and cooling with ice with a suspension of 8.7 g (81.9 mmol) of sodium carbonate in 50 ml of ice-cold methylene chloride and 5 g (111.1 mmol) of dimethylamine, the suspension being added in one portion. After the addition of 60 ml of dry acetonitrile, the mixture is stirred at room temperature for 20 hours and concentrated at 50° C. in vacuo. The residue is suspended in 100 ml of methylene chloride and 100 ml of water and filtered off. The material remaining is dissolved in 80 ml of hot ethanol and left to stand at -10° C. overnight. After filtering off the resulting crystals, there is obtained 3-[6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]-benzodiazepin-8-yl]-1,1-dimethylurea of melting point 186° C. (decomposition).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04374773 |
|---|
| Source dataset | uspto-grants-1983_02 |
|---|
| ORD ID | ord-aa114f090e7a4fc68f6a5cb7f31021ce |
|---|
| Source note | uspto-grants-1983_02 |
|---|